{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:53:44Z","timestamp":1780646024205,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1160.18.038"],"award-info":[{"award-number":["1160.18.038"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jtha.2025.05.023","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:16:10Z","timestamp":1748430970000},"page":"2751-2762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A repeated time-to-event model for personalized treatment of patients with hemophilia A based on individual bleeding risk"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-0831","authenticated-orcid":false,"given":"Alexander","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C.","family":"Bennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A.A.","family":"Math\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.05.023_bib1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/jth.13867","article-title":"Estimating and interpreting the pharmacokinetic profiles of individual patients with hemophilia A or B using a population pharmacokinetic approach: communication from the SSC of the ISTH","volume":"15","author":"Iorio","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.023_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of Hemophilia panelists and co-authors. WFH guidelines for the management of hemophilia","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.05.023_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1538-7836.2008.03270.x","article-title":"Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A","volume":"7","author":"Collins","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.023_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2516.2010.02383.x","article-title":"Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels","volume":"17","author":"Den","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.05.023_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1033416","article-title":"Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases","volume":"9","author":"Valke","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2025.05.023_bib6","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/bcp.15185","article-title":"Combining factor VIII levels and thrombin\/plasmin generation: a population pharmacokinetic-pharmacodynamic model for patients with haemophilia A","volume":"88","author":"Bukkems","year":"2022","journal-title":"Br J Clinical Pharmacol"},{"key":"10.1016\/j.jtha.2025.05.023_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/hae.13935","article-title":"A new paradigm for personalized prophylaxis for patients with severe haemophilia A","volume":"26","author":"Delavenne","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.05.023_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/hae.13493","article-title":"Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq (human-cl rhFVIII) in previously treated patients with severe haemophilia A","volume":"24","author":"Dargaud","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.05.023_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/a-1983-0594","article-title":"Association between sports participation, factor VIII levels and bleeding in hemophilia A","volume":"123","author":"Bukkems","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.023_bib10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3324\/haematol.2019.217133","article-title":"Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients","volume":"105","author":"Abrantes","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.05.023_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/psp4.12938","article-title":"Relationship between factor VIII levels and bleeding for rFVIII-SingleChain in severe hemophilia A: a repeated time-to-event analysis","volume":"12","author":"Bukkems","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.jtha.2025.05.023_bib12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2016-01-687434","article-title":"Efficacy and safety of rVIII-SingleChain: results of a phase 1\/3 multicenter clinical trial in severe hemophilia A","volume":"128","author":"Mahlangu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.05.023_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12665","article-title":"Recombinant single-chain factor VIII in severe hemophilia: long-term safety and efficacy in previously treated patients in the AFFINITY extension study","volume":"6","author":"Mahlangu","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.023_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/jth.13647","article-title":"Safety, efficacy and pharmacokinetics of rVIII-SingleChain in children with severe hemophilia A: results of a multicenter clinical trial","volume":"15","author":"Stasyshyn","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.023_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/jth.13932","article-title":"International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories","volume":"16","author":"Ledger","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.05.023_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/psp4.12464","article-title":"Bayesian forecasting utilizing bleeding information to support dose individualization of factor VIII","volume":"8","author":"Abrantes","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.jtha.2025.05.023_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5334\/jors.151","article-title":"Differentialequations. Jl\u2014a performant and feature-rich ecosystem for solving differential equations in Julia","volume":"5","author":"Rackauckas","year":"2017","journal-title":"J Open Res Softw"},{"key":"10.1016\/j.jtha.2025.05.023_bib18","series-title":"An introduction to variational inference","author":"Ganguly","year":"2021"},{"key":"10.1016\/j.jtha.2025.05.023_bib19","first-page":"3474","article-title":"Sticking the landing: simple, lower-variance gradient estimators for variational inference","volume":"30","author":"Roeder","year":"2017","journal-title":"Adv Neural Inform Process Syst"},{"key":"10.1016\/j.jtha.2025.05.023_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1145\/3368555.3384454","article-title":"Variational learning of individual survival distributions","volume":"2020","author":"Xiu","year":"2020","journal-title":"Proc ACM Conf Health Inference Learn"},{"key":"10.1016\/j.jtha.2025.05.023_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J Cell Physiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625003423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:02:17Z","timestamp":1778868137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625003423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1538783625003423"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.05.023","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A repeated time-to-event model for personalized treatment of patients with hemophilia A based on individual bleeding risk","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}